Congress honors global health pioneer—then demands $125B annual aid commitment
H.Res. 629 — Honoring the life of Dr. Paul Farmer by recognizing the duty of the Federal Government to adopt a 21st-century global health solidarity strategy and take actions to address past and ongoing harms that undermine the health and well-being of people around the world. · Filed by Jan Schakowsky (D-IL) · 13 cosponsors · Introduced Aug 1, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This resolution honors Dr. Paul Farmer and calls on the U.S. federal government to adopt a comprehensive global health strategy focused on ending preventable deaths in poor countries. It proposes increasing U.S. development assistance to 0.7% of gross national income (currently 0.17%), dedicating $125 billion annually to global health, and addressing what it frames as historical economic injustices—including colonialism, slavery, structural adjustment programs, and capital flight—that it argues have depleted developing nations' ability to fund their own health systems. The resolution also calls for debt cancellation, reform of global governance institutions, and reparations for slavery and colonialism.
Why we flagged it
While framed as honoring Dr. Paul Farmer, the resolution is functionally a non-binding sense-of-Congress statement demanding major shifts in U.S. foreign aid, global governance, and reparations policy. The memorial framing is secondary to the policy agenda.
What the text implies
- The $125B annual global health commitment, if enacted, would represent a 10x increase over current global health spending and would require either new revenue or reallocation from domestic programs—neither is addressed.
- The resolution's call for 'debt cancellation for all low- and middle-income countries in need' could affect U.S. bilateral loan portfolios and multilateral institution voting power, with unclear fiscal consequences.
The full analysis lists 5 implications of this text.
Who stands to gain
developing-country governments and health systems; global health NGOs and multilateral health organizations (WHO, GAVI, Global Fund); pharmaceutical companies (if R&D for neglected diseases is funded)